KNKate Nelson
Kate Nelson
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Kate Nelson has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Kalyan Banda
Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, USA
2 shared publications - Abby E. Floeter
Department of Pharmacy Services, Seattle Cancer Care Alliance, Seattle, WA 98109
1 shared publication Amy Indorf
Department of Pharmacy Services, Seattle Cancer Care Alliance, Seattle, WA 98109
1 shared publication- Amy Indorf
Department of Pharmacy, UW Medicine, Seattle, WA; Department of Pharmacy, Fred Hutchinson Cancer Center, Seattle, WA
1 shared publication - Caitlin J. Risener
Emory University
1 shared publication - Cassandra Leah Quave
Center for the Study of Human Health, Emory University, 1557 Dickey Drive, Anthropology 306, Atlanta, Georgia30322, United States
1 shared publication
Latest Publications
- 23 May 2025
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 35 (12) , 101948
Human epidermal growth factor receptor 2 targeted agents in gynecologic cancers: an updated review
- 23 May 2025
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 35 (12) , 101948
Human epidermal growth factor receptor 2 targeted agents in gynecologic cancers: an updated review
- 1 April 2022
- Published by Elsevier in Clinical Breast Cancer
- Vol. 22 (3) , e310-e318
A Retrospective Analysis of Metronomic Cyclophosphamide, Methotrexate, and Fluorouracil (CMF) Versus Docetaxel and Cyclophosphamide (TC) as Adjuvant Treatment in Early Stage, Hormone Receptor Positive, HER2 Negative Breast Cancer
- 1 April 2022
- Published by Elsevier in Clinical Breast Cancer
- Vol. 22 (3) , e310-e318
A Retrospective Analysis of Metronomic Cyclophosphamide, Methotrexate, and Fluorouracil (CMF) Versus Docetaxel and Cyclophosphamide (TC) as Adjuvant Treatment in Early Stage, Hormone Receptor Positive, HER2 Negative Breast Cancer
- 1 June 2021
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 141 (6) , 1588-1591
Staphylococcal Hemolytic Potential Is Correlated with Increased Severity of Atopic Dermatitis in Children and Young Adults
- 1 June 2021
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 141 (6) , 1588-1591
Staphylococcal Hemolytic Potential Is Correlated with Increased Severity of Atopic Dermatitis in Children and Young Adults